ATRS
Price:
$5.59
Market Cap:
$0
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingu...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
1996-10-03
Stock Exchange
NASDAQ
Ticker
ATRS
According to Antares Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 31.40%. This represents a change of 379.63% compared to the average of 6.55% of the last 4 quarters.
The mean historical ROE of Antares Pharma, Inc. over the last ten years is -20.90%. The current 31.40% ROE has changed -250.23% with respect to the historical average. Over the past ten years (40 quarters), ATRS's ROE was at its highest in in the December 2020 quarter at 43.14%. The ROE was at its lowest in in the December 2014 quarter at -24.45%.
Average
-20.90%
Median
-22.85%
Minimum
-85.33%
Maximum
47.18%
Discovering the peaks and valleys of Antares Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 194.24%
Maximum Annual ROE = 47.18%
Minimum Annual Increase = -1368.59%
Minimum Annual ROE = -85.33%
Year | ROE | Change |
---|---|---|
2021 | 26.34% | -44.18% |
2020 | 47.18% | -1368.59% |
2019 | -3.72% | -77.74% |
2018 | -16.70% | -66.53% |
2017 | -49.91% | -7.28% |
2016 | -53.82% | 74.67% |
2015 | -30.81% | -63.89% |
2014 | -85.33% | 194.24% |
2013 | -29.00% | 119.64% |
2012 | -13.20% | -6.29% |
The current ROE of Antares Pharma, Inc. (ATRS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
23.27%
5-year avg
0.64%
10-year avg
-20.90%
Antares Pharma, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antares Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Antares Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Antares Pharma, Inc.'s ROE?
How is the ROE calculated for Antares Pharma, Inc. (ATRS)?
What is the highest ROE for Antares Pharma, Inc. (ATRS)?
What is the 3-year average ROE for Antares Pharma, Inc. (ATRS)?
What is the 5-year average ROE for Antares Pharma, Inc. (ATRS)?
How does the current ROE for Antares Pharma, Inc. (ATRS) compare to its historical average?